WinstonWınston
CAMP4 Therapeutics Corporation logo

CAMP4 Therapeutics Corporation

CAMP
31
Biotechnology · Healthcare
Exchange
NASDAQ
Winston Score
31
Winston is serious
Below-average fundamentals — multiple weak pillars.

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+50.8% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+50.0% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

86.9%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~2 years

$99M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

$99M cash & investments at current burn rate

Revenue accelerating

CAMP4 Therapeutics Corporation grew revenue 51% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
59.8%
Premium pricing power — 59.8% gross margin
Operating Margin
-1010.1%
Losing money on operations — -1010.1%
ROCE
-39.6%
Weak — -39.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+160.5%
Fast-growing sales (160.5% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-667.2%
Burning cash (-667.2%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.07
Conservative — low debt load (0.07)
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial